Celgene (CELG), Acceleron (XLRN) Offer Prelim. Data from Luspatercept Phase 2 in MDS; Increased Hemoglobin Levels Noted
Tweet Send to a Friend
Acceleron Pharma Inc. (Nasdaq: XLRN) and Celgene Corporation (Nasdaq: CELG) announced preliminary results from an ongoing long-term Phase 2 extension ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
